IOBT icon

IO Biotech

15 hedge funds and large institutions have $24M invested in IO Biotech in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NHAS
1
Novo Holdings A/S
Denmark
$6.41M 3,277,932
VC
2
Vivo Capital
California
$5.9M 3,015,545
ACA
3
Avoro Capital Advisors
New York
$4.03M 2,055,883
Bank of America
4
Bank of America
North Carolina
$3.62M 1,854,185
SB
5
Samsara BioCapital
California
$1.97M 1,008,437
PHS
6
PFM Health Sciences
California
$1.2M 612,713 +105,073 +21%
BCM
7
Bridgeway Capital Management
Texas
$259K 132,200
Renaissance Technologies
8
Renaissance Technologies
New York
$135K 69,100 +7,400 +12%
Morgan Stanley
9
Morgan Stanley
New York
$135K 68,948 +25,753 +60%
STA
10
Summit Trail Advisors
New York
$85.5K 43,744 +43,744 New
AAM
11
Aureus Asset Management
Massachusetts
$85.5K 43,744 +43,744 New
Citadel Advisors
12
Citadel Advisors
Florida
$73.9K 37,690 -9,152 -20%
TSS
13
Two Sigma Securities
New York
$25.5K 13,020 +13,020 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$25K 12,730
AA
15
Ancora Advisors
Ohio
$1.78K 908
Point72 Asset Management
16
Point72 Asset Management
Connecticut
-1,400,000 Closed
Capital World Investors
17
Capital World Investors
California
-418,499 Closed
NM
18
Newtyn Management
New York
-49,346 Closed
Millennium Management
19
Millennium Management
New York
-19,917 Closed
CC
20
Cannell Capital
Wyoming
-12,594 Closed
CFGS
21
Concourse Financial Group Securities
Alabama